U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215585) titled 'AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL' on Oct. 07.
Brief Summary: The purpose of this study is to measure the efficacy and safety of R-mini-CHOP x 2 followed by AZD0486 compared with R-mini-CHOP x 6 in elderly or unfit participants newly diagnosed with LBCL.
Study Start Date: Nov. 02
Study Type: INTERVENTIONAL
Condition:
Large B-cell Lymphoma
Intervention:
DRUG: AZD0486
Bispecific monoclonal IgG4 antibody
DRUG: R-mini-CHOP
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services with p...